Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement
Lung Cancer(2020)
Abstract
•Various clinical trials are investigating immune checkpoint inhibitors in mesothelioma patients.•We report a mesothelioma patient with 100 % PDL1 expression in brain metastasis.•The patient was treated with pembrolizumab, achieving impressive clinical response.
MoreTranslated text
Key words
MPM,OS,PD-L1,CTLA-4,18FDG-PET/CT,MRI,IHC,FISH,NGS,ALK,EML4,MET
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined